Skip to main content
Egyptian Liver Journal

Table 5 Comparison between cases with and without MS as regards SBP, serum TGs, and CIMT

From: Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk

Variable

Cases with MS

Cases without MS

p

 

(n = 18)

(n = 42)

 

TGs (mg/dl)

143.9 ± 29.4

116 ± 25.8

0.028

SBP (mmHg)

137.22 ± 6.18

127.14 ± 10.316

< 0.0

CIMT (mm)

0.9 ± 0.1

0.67 ± 0.09

< 0.01

NAFLD-LFS

1.19 (− 0.5 to 2.57)

− 1.245 (− 1.8 to 1.27)

< 0.01*

  1. MS metabolic syndrome, SBP systolic blood pressure, TGs triglycerides, CIMT carotid intima-media thickness, NAFLD-LFS non-alcoholic fatty liver disease-liver fibrosis score
  2. *Mann-Whitney (z) test
Back to article page